We aim to recruit 20 male and female, older (60-75 y) non-obese subjects 
Sample size
The primary outcome of the study was the effect of nitrate supplementation on VO 2 consumption during sub-maximal exercise. Data on the expected effect size was were obtained from a previous cross-over design study testing the effects of incremental exercise on sub-maximal and maximal O2 consumption in young adults after a six-day nitrate supplementation which showed that V Ȯ2 during moderate exercise was 1.53±0.12 L·min-1 and 1.45±0.12 L·min-1 in the placebo and nitrate groups respectively (1) . On this basis, 20 participants were needed in a cross-over randomised trial to detect a difference of 0.08±0.12 L·min-1 with a power of 0.80 and alpha of 0.05. In addition, 18 subjects would be sufficient to detect a difference in systolic blood pressure of 4.4±6.0 mmHg between the placebo and intervention groups with a power of 0.80 and alpha of 0.05. The effect size for this calculation is derived from the meta-analysis conducted by Siervo et al in 2013 (2) .
Randomisation
A randomisation list for each site was generated by a member of staff not involved in the study using www.sealedenvelopes.com. Each participant was randomised to the cross-over interventions (i.e., placebo  3 − or 3 −  placebo). Intervention agents were dispensed at each baseline visit by two members of staff not involved in the study.
Measurement of plasma biomarkers
Plasma glucose was measured by standard automated enzymatic methods using an Olympus AU 640 analyser (Olympus, Watford, UK). Fasting insulin was measured by immunoassay (ELISA; Dako UK Ltd, Ely, UK) and the Homeostatic Model of Insulin Resistance (HOMA-IR) was calculated 17 . Interleukin-6 (IL-6) by high-sensitivity ELISA immunoassay (Human IL-6 Quantikine HS ELISA Kit, R&D Systems, Minneapolis, Minnesota, USA). Serum concentrations of cyclic guanosine monophosphate (cGMP) and 3-nitrotyrosine (3-NT) were determined in duplicate using a high-sensitivity, quantitative ELISA kits according to the manufacturer's instructions. Commercial Meso Scale Discovery kits (Meso Scale Discovery, Gaithersburg, MD, USA) were used for the measurement of plasma P-selectin, E-Selectin, intercellular adhesion molecule-3 (ICAM-3) and thrombomodulin. Plasma Endothelin-1 (ET-1) concentrations were measured using the Quantikine Endothelin-1 immunoassay (ET-1 Quantikine ELISA Kit, R&D Systems, Minneapolis, Minnesota, USA). 
